topiramate NDC 70518-4515

Product information

Brand name (proprietary)

topiramate

Generic name (nonproprietary)

topiramate

Active ingredients

Topiramate — 25 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

REMEDYREPACK INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 090162

Marketing start

Nov 4, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 70518-4515_5b88213b-13cf-0048-e063-6394a90a51ddSPL ID 5b88213b-13cf-0048-e063-6394a90a51dd

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518451500 followed by a unit qualifier and the quantity Copy

Package 70518-4515-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 090162

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 34.